Search Ontology:
ChEBI
beta-D-Galp-(1->4)-beta-D-Glcp-(1->3)-D-GalpNAc
- Term ID
- CHEBI:147089
- Synonyms
-
- beta-D-galacto-hexopyranosyl-(1->4)-beta-D-gluco-hexopyranosyl-(1->3)-2-acetamido-2-deoxy-D-galacto-hexopyranose
- beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranosyl-(1->3)-2-acetamido-2-deoxy-D-galactopyranose
- Gal(b1-4)Glc(b1-3)GalNAc
- N-[(3R,4R,5R,6R)-4-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-2,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
- Definition
- An amino trisaccharide consisting of β-D-galactopyranose, β-D-glucopyranose and 2-acetamido-2-deoxy-D-galactopyranose residues joined in sequence by (1→4) and (1→3) glycosidic bonds.
- References
-
- glygen:G10149FE
- glytoucan:G10149FE
- kegg.glycan:G08389
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from beta-D-Galp-(1->4)-beta-D-Glcp-(1->3)-D-GalpNAc
Phenotype where environments contain beta-D-Galp-(1->4)-beta-D-Glcp-(1->3)-D-GalpNAc
Phenotype modified by environments containing beta-D-Galp-(1->4)-beta-D-Glcp-(1->3)-D-GalpNAc
Phenotype affecting beta-D-Galp-(1->4)-beta-D-Glcp-(1->3)-D-GalpNAc
Human Disease Model